Accent Microcell (ACCENTMIC.NS) Stock Price

Accent Microcell Price

CLOSED
586.20
​
Market closed

Over the last 2 years Accent Microcell grew revenue by 15.8% annually, reaching 5.29 B INR. Earnings per share have declined at 70.1% per year over the last 2 years. For Accent Microcell, the net margin of 12.5% is down versus 115.5% a few years ago. At today's price the dividend yield works out to roughly 0.17%. The payout ratio is around 3% of earnings.

Accent Microcell stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Accent Microcell business model & stock analysis

Accent Microcell Ltd develops, processes, and markets a wide range of pharmaceutical products including bulk drugs, formulations in all forms, feed and dietary supplements, and healthcare products across allopathic, ayurvedic, umami, homeopathic, and other branches. The company manufactures and sells antibiotics, herbal, bacteriological, and biological products, as well as insecticides, pesticides, fungicides, and disinfectants. With over 200 products in its portfolio, Accent Microcell targets therapeutic segments in human and veterinary healthcare, offering both raw materials and finished preparations for diverse medical applications. The company's product range includes microcrystalline cellulose powder and alpha cellulose powder, which are used as pharmaceutical excipients. Accent Microcell Limited deals in all kinds of drugs and medicines, covering various therapeutic areas such as antibiotics, herbal remedies, and veterinary applications. Its business model focuses on manufacturing, importing, and exporting these products to meet demand in multiple healthcare sectors. Accent Microcell Ltd's revenue streams come from selling bulk drugs, pharmaceutical formulations, and healthcare products to distributors, pharmacies, and veterinary suppliers. The company's diverse portfolio of over 200 products ensures steady demand across different therapeutic segments, supporting consistent sales in both human and veterinary healthcare markets.

Frequently asked questions about Accent Microcell

Converted at the current exchange rate, the Accent Microcell share trades at 5.72 EUR (586.20 INR).

The revenue cannot currently be calculated for Accent Microcell.

The profit cannot currently be calculated for Accent Microcell.

The P/E ratio cannot be calculated for Accent Microcell at the moment.

The P/S cannot be calculated for Accent Microcell currently.

The Eulerpool Quality Score for Accent Microcell is 4/10.

The ISIN of Accent Microcell is INE0Q5D01013. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Accent Microcell is ACCENTMIC.NS. The ticker symbol is used to trade Accent Microcell shares on the stock exchange.

Fair ValueTerminal
586.20 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Dec 15, 2023
ISIN
INE0Q5D01013
Cusip
Y0S27A109
Market capitalization
14.06 B INRLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
17.70
P/B Ratio
7.22
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
33.69 %
Dividend
Dividend yield
0.17 %
Payout Ratio
3.36 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
2 years
Dividend not reduced since
2 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Nov 22, 2026, 12:07 AM

Accent Microcell Peer Group